🧬
Gen Terapisi Sektörü Hisseleri
Gen Terapisi Sektörü altında 55 Hisse Senedi
Gen Terapisi sektöründe faaliyet gösteren ABD şirketlerinin hisse senetleri. Gerçek zamanlı fiyatlar, finansal analizler ve detaylı şirket bilgileri.
55
Toplam Hisse
$35.9B
Toplam Piyasa Değeri
Gen Terapisi Sektörü Hisseleri
| SEMBOL | ŞİRKET | PİYASA DEĞERİ | FİYAT | DEĞİŞİM |
|---|---|---|---|---|
| KRYS | Krystal Biotech, Inc. | $5.25B | $181.47 | 3.86% |
| ACLX | Arcellx, Inc. | $4.81B | $86.80 | 1.80% |
| LEGN | Legend Biotech Corporation | $2.91B | $31.70 | 1.61% |
| BEAM | Beam Therapeutics Inc. | $2.66B | $26.32 | 5.56% |
| SRPT | Sarepta Therapeutics, Inc. | $2.16B | $22.11 | 4.41% |
| DYN | Dyne Therapeutics, Inc. | $2.00B | $14.05 | 4.29% |
| STOK | Stoke Therapeutics, Inc. | $1.65B | $30.19 | 0.97% |
| TSHA | Taysha Gene Therapies, Inc. | $1.16B | $4.88 | 2.40% |
| SANA | Sana Biotechnology, Inc. | $1.03B | $4.32 | 2.92% |
| PRME | Prime Medicine, Inc. | $1.01B | $5.68 | 8.83% |
| IOVA | Iovance Biotherapeutics, Inc. | $759.89M | $2.10 | 4.11% |
| MGTX | MeiraGTx Holdings plc | $630.45M | $7.84 | 10.50% |
| RGNX | REGENXBIO Inc. | $551.62M | $10.92 | 10.27% |
| ARCT | Arcturus Therapeutics Holdings Inc. | $514.58M | $18.95 | 3.71% |
| FULC | Fulcrum Therapeutics, Inc. | $486.28M | $8.99 | 6.55% |
| SLDB | Solid Biosciences Inc. | $464.10M | $5.96 | 6.88% |
| NGNE | Neurogene Inc. | $431.15M | $30.21 | 4.28% |
| FDMT | 4D Molecular Therapeutics, Inc. | $415.62M | $8.90 | 6.90% |
| KRRO | Korro Bio, Inc. | $403.53M | $42.97 | 8.07% |
| BNTC | Benitec Biopharma Inc. | $391.66M | $14.92 | 5.07% |
| DSGN | Design Therapeutics, Inc. | $384.40M | $6.75 | 5.20% |
| LRMR | Larimar Therapeutics, Inc. | $373.17M | $4.36 | 4.18% |
| RCKT | Rocket Pharmaceuticals, Inc. | $369.03M | $3.42 | 6.81% |
| REPL | Replimune Group, Inc. | $353.59M | $4.53 | 2.16% |
| TNYA | Tenaya Therapeutics, Inc. | $342.25M | $2.10 | 3.96% |
| EDIT | Editas Medicine, Inc. | $334.50M | $3.72 | 8.82% |
| LYEL | Lyell Immunopharma, Inc. | $317.18M | $16.51 | 12.51% |
| KYTX | Kyverna Therapeutics, Inc. | $286.72M | $6.63 | 6.09% |
| ABEO | Abeona Therapeutics Inc. | $274.85M | $5.36 | 5.30% |
| LXEO | Lexeo Therapeutics, Inc. Common Stock | $273.54M | $8.24 | 0.49% |
| ALLO | Allogene Therapeutics, Inc. | $272.90M | $1.23 | 18.54% |
| TSVT | 2seventy bio, Inc. | $266.14M | $5.00 | 0.00% |
| RNAC | Cartesian Therapeutics, Inc. | $242.34M | $9.32 | 7.72% |
| TRDA | Entrada Therapeutics, Inc. | $231.65M | $6.09 | 10.31% |
| CRGX | CARGO Therapeutics, Inc. Common Stock | $216.19M | $4.47 | 0.00% |
| CABA | Cabaletta Bio, Inc. | $212.20M | $2.32 | 18.60% |
| SGMO | Sangamo Therapeutics, Inc. | $202.84M | $0.67 | 9.01% |
| FATE | Fate Therapeutics, Inc. | $188.56M | $1.64 | 1.55% |
| PEPG | PepGen Inc. | $154.65M | $4.71 | 6.26% |
| NKTX | Nkarta, Inc. | $153.41M | $2.16 | 8.47% |
| TIL | Instil Bio, Inc. | $129.82M | $19.23 | 7.33% |
| ADVM | Adverum Biotechnologies, Inc. | $100.93M | $4.81 | 9.59% |
| ATRA | Atara Biotherapeutics, Inc. | $100.60M | $14.32 | 10.91% |
| ACET | Adicet Bio, Inc. | $80.52M | $0.97 | 5.80% |
| ARTV | Artiva Biotherapeutics, Inc. | $68.64M | $2.81 | 6.33% |
| DTIL | Precision BioSciences, Inc. | $66.24M | $5.62 | 4.42% |
| INKT | MiNK Therapeutics, Inc. | $63.30M | $14.00 | 3.78% |
| BLUE | bluebird bio, Inc. | $48.67M | $4.97 | 0.00% |
| GBIO | Generation Bio Co. | $41.15M | $6.11 | 3.17% |
| PASG | Passage Bio, Inc. | $26.93M | $8.47 | 2.52% |
| PHIO | Phio Pharmaceuticals Corp. | $10.57M | $2.20 | 6.69% |
| ERNA | Eterna Therapeutics Inc. | $9.93M | $1.29 | 3.36% |
| TCRT | Alaunos Therapeutics, Inc. | $7.64M | $3.48 | 12.78% |
| GNPX | Genprex, Inc. | $6.91M | $0.21 | 11.33% |
| CARM | Carisma Therapeutics, Inc. | $6.43M | $0.15 | 43.81% |